. 2022 Oct 6;1-6.
doi: 10.1080/09546634.2022.2127308.
Online ahead of print.
- PMID: 36200741
- DOI: 10.1080/09546634.2022.2127308
Abstract
Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities. Current treatments often prove unsatisfactory, especially in sufferers of generalized hyperhidrosis. In this open trial, we present the case of a refractory generalized hyperhidrosis treated with cannabinoids. We found a remarkable reduction in the volume of sweat and an improvement to the patient’s quality of life using this novel low-cost and low-impact approach.
Keywords: THC, Tetrahydrocannabinol, cannabis, dronabinol, sweat
Similar articles
-
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Cochrane Database Syst Rev. 2022 May 5;5(5):CD013444. doi: 10.1002/14651858.CD013444.pub2.PMID: 35510826 Review. -
Finding cannabinoids in hair does not prove cannabis consumption.
Sci Rep. 2015 Oct 7;5:14906. doi: 10.1038/srep14906.PMID: 26443501 Free PMC article. -
Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use.
Clin Chim Acta. 2020 Nov;510:515-521. doi: 10.1016/j.cca.2020.08.014. Epub 2020 Aug 12.PMID: 32795544 -
Phytother Res. 2021 Mar;35(3):1646-1657. doi: 10.1002/ptr.6931. Epub 2020 Nov 6.PMID: 33155722
-
Evaluating the patient presenting with hyperhidrosis.
Thorac Surg Clin. 2008 May;18(2):133-140. doi: 10.1016/j.thorsurg.2008.01.002.PMID: 18557587 Review.
